# Role of Next Generation Sequencing in the Etiological Diagnosis of Permanent Congenital Hypothyroidism With in Situ Thyroid

> **NCT06728735** · — · RECRUITING · sponsor: **IRCCS Azienda Ospedaliero-Universitaria di Bologna** · enrollment: 350 (estimated)

## Conditions studied

- Congenital Hypothyroidism

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06728735
- **Lead sponsor:** IRCCS Azienda Ospedaliero-Universitaria di Bologna
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-03-17
- **Primary completion:** 2027-11-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2026-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06728735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06728735, "Role of Next Generation Sequencing in the Etiological Diagnosis of Permanent Congenital Hypothyroidism With in Situ Thyroid". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06728735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*